Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Anemia 4Myelodysplastic Syndromes 3Myeloproliferative Disorders 2Leukemia 2Neoplasms, Plasma Cell 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fatigue 1Breast Neoplasms 1

Interventions

Therapeutics 2Psychiatric Rehabilitation 2Mental Status and Dementia Tests 2Early Intervention, Educational 2epoetin beta 1Yoga 1Vinorelbine 1Sodium Chloride 1Modafinil 1Midazolam 1Mass Spectrometry 1Ketamine 1Epoetin Alfa 1Caregivers 1Carboplatin 1Analgesia 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Fatigue × Epoetin Alfa × Clear all
NCT00022386 2013-07-18

Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 4 Completed
BreastClassical hematology

Anemia, Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡